Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Cell Biology International|February 5, 2004
N-acetyl-GLP-1: a DPP IV-resistant analogue of glucagon-like peptide-1 (GLP-1) with improved effects on pancreatic beta-cell-associated gene expressionHui-Kang Liu, Brian D Green, Victor A Gault, et al.Biological Chemistry|October 7, 2005
Antidiabetic potential of two novel fatty acid derivatised, N-terminally modified analogues of glucose-dependent insulinotropic polypeptide (GIP): N-AcGIP(LysPAL16) and N-AcGIP(LysPAL37)Nigel Irwin, Victor A Gault, Brian D Green, et al.Journal of Medicinal Chemistry|February 3, 2006
GIP(Lys16PAL) and GIP(Lys37PAL): novel long-acting acylated analogues of glucose-dependent insulinotropic polypeptide with improved antidiabetic potentialNigel Irwin, Finbarr P M O'Harte, Victor A Gault, et al.The Journal of Endocrinology|June 15, 2017
Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic micePaul Millar, Nupur Pathak, Vadivel Parthsarathy, et al.Biochemical Pharmacology|July 25, 2006
Evaluation of the antidiabetic activity of DPP IV resistant N-terminally modified versus mid-chain acylated analogues of glucose-dependent insulinotropic polypeptideNigel Irwin, Gillian C Clarke, Brian D Green, et al.The Journal of Biological Chemistry|April 20, 2006
NMR and alanine scan studies of glucose-dependent insulinotropic polypeptide in waterIñigo Alaña, Jeremy C Parker, Victor A Gault, et al.Diabetes/Metabolism Research and Reviews|February 23, 2007
Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amideNigel Irwin, Paula L McClean, Roslyn S Cassidy, et al.Biochimica Et Biophysica Acta|January 24, 2016
A novel chemically modified analogue of xenin-25 exhibits improved glucose-lowering and insulin-releasing propertiesVadivel Parthsarathy, Nigel Irwin, Annie Hasib, et al.American Journal of Physiology. Endocrinology and Metabolism|February 15, 2007
Antagonistic effects of two novel GIP analogs, (Hyp3)GIP and (Hyp3)GIPLys16PAL, on the biological actions of GIP and longer-term effects in diabetic ob/ob miceFinbarr P M O'Harte, Kerry Hunter, Victor A Gault, et al.Biological Chemistry|April 23, 2004
Degradation, receptor binding, insulin secreting and antihyperglycaemic actions of palmitate-derivatised native and Ala8-substituted GLP-1 analoguesBrian D Green, Victor A Gault, Mark H Mooney, et al.Pageof 10